Most centers are not sticking to recommended thresholds found on the troponin assays’ package inserts, a recent survey found.

In the small study of women with no CVD, up to 57% of ECGs from those with implants were classified as abnormal.

Top-line trial results, to be presented in full this summer, represent the first hard proof of the inflammation hypothesis of atherosclerosis.

Rather than being “inappropriate,” off-label treatment may be a reasonable choice in patients with few other options, experts say.

A real-world test showed that “app rescuers” arrived more than 3 minutes before an ambulance in 36% of cardiac arrests.

The noninvasive approach could one day be used to improve valve movement in deteriorating devices, a proof-of-concept study suggests.

One expert says he will start discontinuing aspirin in appropriate A-fib patients as a result of these new findings.

Having ideal CV health lowers mortality and vascular event risks even when other chronic diseases are present, researchers say.

Despite the benefits, one expert warns that even the most prepared operators can get into turbulence during minimalist TAVR procedures.